Thomas Lee was the Minnesota Bureau Chief for MedCityNews.
Fund founder Jim O'Reilly says it was "fairly impossible" to raise money. For O'Reilly, explaining Upwind to potential investors proved to be a challenge in itself. For one thing, O'Reilly insisted Upwind was not a "fund" but rather a "new model" for developing startups.
Applied Bioprocess Containers LLC has raised $1.03 million from the sale of equity, about $30,000 shy of its goal, according to documents filed with the Securities and Exchange Commission.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Nascent Surgical LLC raised $223,000 from the sale of equity, according to documents filed with the Securities and Exchange Commission.
Biolyst LLC is seeking $1.25 million from the sale of equity and warrants, according to documents filed with the Securities and Exchange Commission.
The hearing aid system is supposed to boost the outer ear's natural ability to direct and amplify high frequency sound and reduce wind noise. It's made by ReSound, a medical device company based in Bloomington, Minnesota. The company said the Remote Microphone Technology provides users a more appealing cosmetic look by tucking the microphone in the concha cymba area of the external ear.
Private equity firm Riverside Co. has acquired CareFacts Information Systems, based in St. Paul, Minnesota, for an undisclosed amount.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Life science current events will collide with political realities in Minnesota. Last year the medical industry made important strides, including winning an angel investment tax credit. This year healthcare interests will likely be on the defensive. The University of Minnesota, the Biomedical Discovery District and health services for the poor are on the chopping block.
In his research report, Morgan Stanley analyst David Lewis says St. Jude faces significant challenges -- both big picture and small picture.
Medtronic (NYSE:MDT) announced this week that CEO Bill Hawkins will retire in April 2011 after just three-plus years on the job. While his tenure was relatively short, Hawkins left an indelible mark on the world's largest maker of new innovative medical devices. Here's a look back on the Hawkins era at Medtronic.
The University of Minnesota said its scientists have discovered a possible way to stop the spread of the virus that causes AIDS by preventing the pathogen from attaching itself to an antiviral protein. APOBEC3F belongs to a family of proteins that defend the body against viruses. The HIV virus, however, has developed an ability to attach itself to the protein and destroy it.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
GT Urological has raised $4.56 million from the sale of equity, according to documents filed with the Securities and Exchange Commission.
Thank God for St. Jude Medical, pro-investment legislators and hearing device companies plugged by Rush Limbaugh. Thumbs down to Boston Scientific, a diminishing amount of venture capital and boondoggle business parks.
The University of Minnesota said Wednesday that scientists have established a firm relationship between a protein known as tau and Alzheimer’s disease, the most common form of elderly dementia in the United States. In a study published in the journal Neuron, researchers say that an early buildup of tau in the dendritic spines, a region […]
BridgePoint Medical Inc. has raised $9.1 million from the sale of equity. The company based in Plymouth, Minnesota, is developing balloon catheter system to treat chronic coronary and peripheral total occlusions, a condition in which clots frequently clog blood vessels.
The FDA approval of the Endurant system adds yet another stent to the list of Medtronic's cadriovascular products. The company is relying on new innovative medical devices to continue to grow revenue. Medtronic estimates 1.2 million Americans suffer from abdominal aortic aneurysms, which will be treated by Endurant.